Social Listening and the Pharma IndustryBrandwatch
Changing patient expectations and the increasing influence of social media, together with heightened government regulatory activity and a growing trend of alliances and acquisitions, represent a shifting landscape.
Pharmaceutical companies need to respond dynamically to this evolution by implementing new business models. Next-generation business models must address a number of key factors to position themselves for long-term success, one of which is to listen and ultimately engage in meaningful dialogue with consumers and stakeholders.
In this white paper, we seek to explore:
Key challenges facing pharmaceutical companies in their forays into social listening.
Benefits of social listening illustrated with reference to a number of case studies drawn from a selection of therapy areas.
Recommendations around how to get started and the role Brandwatch and PharmiWeb Solutions can take to help you achieve business success.
Download today.
Patients Rising: How to Reach Empowered, Digital Health Consumerse-Patient Connections
Kru Research's white paper discussing how to reach out to empowered, digital, health consumers or e-Patients. Discussion of participatory medicine, digital health consumers, e-Patients, web 2.0, the power of social media, ROI of social media, regulatory concerns, HIPAA, FDA, adverse event reporting, and the future of social media in health marketing.
Overcoming Pharma’s Social Media & Mobile Challenges Pharma Guy
This is a presentation I made at a Bayer HealthCare Grants4Apps™ meeting on June 11, 2013, in Berlin. It highlights some pharma social media and mobile app “milestones” or “firsts” that have paved the way for others to follow.
I identify the “Pioneers” who have helped the industry navigate through “uncharted” territory lacking regulatory guidance.
I also analyze some “mistakes” made by both leaders and followers. Only those who learn from thee mistakes of their competitors will move forward. Those who learn from their OWN mistakes will move forward fastest!
Finally, I present some ideas for “best practices” and “guiding principles” that may help you avoid regulatory actions.
Social Listening and the Pharma IndustryBrandwatch
Changing patient expectations and the increasing influence of social media, together with heightened government regulatory activity and a growing trend of alliances and acquisitions, represent a shifting landscape.
Pharmaceutical companies need to respond dynamically to this evolution by implementing new business models. Next-generation business models must address a number of key factors to position themselves for long-term success, one of which is to listen and ultimately engage in meaningful dialogue with consumers and stakeholders.
In this white paper, we seek to explore:
Key challenges facing pharmaceutical companies in their forays into social listening.
Benefits of social listening illustrated with reference to a number of case studies drawn from a selection of therapy areas.
Recommendations around how to get started and the role Brandwatch and PharmiWeb Solutions can take to help you achieve business success.
Download today.
Patients Rising: How to Reach Empowered, Digital Health Consumerse-Patient Connections
Kru Research's white paper discussing how to reach out to empowered, digital, health consumers or e-Patients. Discussion of participatory medicine, digital health consumers, e-Patients, web 2.0, the power of social media, ROI of social media, regulatory concerns, HIPAA, FDA, adverse event reporting, and the future of social media in health marketing.
Overcoming Pharma’s Social Media & Mobile Challenges Pharma Guy
This is a presentation I made at a Bayer HealthCare Grants4Apps™ meeting on June 11, 2013, in Berlin. It highlights some pharma social media and mobile app “milestones” or “firsts” that have paved the way for others to follow.
I identify the “Pioneers” who have helped the industry navigate through “uncharted” territory lacking regulatory guidance.
I also analyze some “mistakes” made by both leaders and followers. Only those who learn from thee mistakes of their competitors will move forward. Those who learn from their OWN mistakes will move forward fastest!
Finally, I present some ideas for “best practices” and “guiding principles” that may help you avoid regulatory actions.
This is the annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010CREATION
Slides from Daniel Ghinn's presentation at DIA (Drug Information Association) 4th Annual Clinical Forum, Lisbon, 13 October 2010.
This session was part of the Medical Information & Communications track, and was aimed at orientating medical information professionals to the role of social media in healthcare engagement. It's a basic introduction to the changing roles of healthcare stakeholders and especially the 'e-Patient'; and includes examples of social media's role in healthcare engagement including a brand new case study of Pfizer's 'Can you feel my pain' strategy in Europe.
Wego Health FDA Post Presentation Data Pptguest4c357f
Annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
Companies can leverage social media to drive business and compete effectively in the new era of health care. But what do you need to know before jumping in or expanding your efforts? What considerations do medical technology marketing professionals need to take into account when implementing a strategic social-media plan?
Part one of our five-part series outlines how medical technology professionals can use social media in a regulated environment. Even more importantly, it gives readers the supporting evidence needed to recommend specific social-media strategies to management and internal legal and regulatory teams.
Social Media The Evolving Patient Physician Connection FinalStephanie Cannon
Getting physicians to recognize, and embrace, the shift to social media may not be easy. Examine proven examples of how social media can be used to strengthen patient and physician interactions, the value of different outlets, and tactics for obtaining buy-in from physicians and other staff.
Stephanie Cannon
Director, Web Communications & eBusiness
Nationwide Children’s Hospital (Columbus, OH)
Elizabeth Scott
President & Principal Consultant
Raven New Media & Marketing, LLC
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...USP e Plexus
Presentation exploring how pharma industry in Brazil and around world are using the web 2.0 to establish interactions with medical community (social networking, twitter, facebook, youtube, linkedin, etc)
Examine why hospitals may want to consider a more comprehensive plan in using social media before hopping on Facebook. If you are already on Facebook examine the issues and re-strategize.
In this presentation originally designed for a live webinar, Story Worldwide and STRIKEFORCE Communications take a look at the current Social Media landscape for Healthcare and Pharma clients, and help teach them how to use digital channels to tell their story and help it spread.
Learn more at http://www.storyworldwide.com or our blog at http://www.postadvertising.com.
Follow us at:
http://www.twitter.com/StoryWorldwide
http://www.twitter.com/PostAdvertising
http://www.fb.me/StoryWorldwide
FDA Regulation of Promotion & Advertising -- Social Media & InternetMichael Swit
November 10, 2017 presentation to the ComplianceOnline course on Ensuring Compliance with FDA Regulation of Promotion & Advertising of Drugs and Medical Devices, in Boston, covering:
Legal issues involving FDA regulation of Social Media
FDA Guidance On Social Media
FDA actions involving Social Media
Best Practices and other Lessons
This is the annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010CREATION
Slides from Daniel Ghinn's presentation at DIA (Drug Information Association) 4th Annual Clinical Forum, Lisbon, 13 October 2010.
This session was part of the Medical Information & Communications track, and was aimed at orientating medical information professionals to the role of social media in healthcare engagement. It's a basic introduction to the changing roles of healthcare stakeholders and especially the 'e-Patient'; and includes examples of social media's role in healthcare engagement including a brand new case study of Pfizer's 'Can you feel my pain' strategy in Europe.
Wego Health FDA Post Presentation Data Pptguest4c357f
Annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
Companies can leverage social media to drive business and compete effectively in the new era of health care. But what do you need to know before jumping in or expanding your efforts? What considerations do medical technology marketing professionals need to take into account when implementing a strategic social-media plan?
Part one of our five-part series outlines how medical technology professionals can use social media in a regulated environment. Even more importantly, it gives readers the supporting evidence needed to recommend specific social-media strategies to management and internal legal and regulatory teams.
Social Media The Evolving Patient Physician Connection FinalStephanie Cannon
Getting physicians to recognize, and embrace, the shift to social media may not be easy. Examine proven examples of how social media can be used to strengthen patient and physician interactions, the value of different outlets, and tactics for obtaining buy-in from physicians and other staff.
Stephanie Cannon
Director, Web Communications & eBusiness
Nationwide Children’s Hospital (Columbus, OH)
Elizabeth Scott
President & Principal Consultant
Raven New Media & Marketing, LLC
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...USP e Plexus
Presentation exploring how pharma industry in Brazil and around world are using the web 2.0 to establish interactions with medical community (social networking, twitter, facebook, youtube, linkedin, etc)
Examine why hospitals may want to consider a more comprehensive plan in using social media before hopping on Facebook. If you are already on Facebook examine the issues and re-strategize.
In this presentation originally designed for a live webinar, Story Worldwide and STRIKEFORCE Communications take a look at the current Social Media landscape for Healthcare and Pharma clients, and help teach them how to use digital channels to tell their story and help it spread.
Learn more at http://www.storyworldwide.com or our blog at http://www.postadvertising.com.
Follow us at:
http://www.twitter.com/StoryWorldwide
http://www.twitter.com/PostAdvertising
http://www.fb.me/StoryWorldwide
FDA Regulation of Promotion & Advertising -- Social Media & InternetMichael Swit
November 10, 2017 presentation to the ComplianceOnline course on Ensuring Compliance with FDA Regulation of Promotion & Advertising of Drugs and Medical Devices, in Boston, covering:
Legal issues involving FDA regulation of Social Media
FDA Guidance On Social Media
FDA actions involving Social Media
Best Practices and other Lessons
The Pharmaguy Social Media Pioneer AwardPharma Guy
The Pharmaguy Social Media Pioneer Award recognizes a pharmaceutical executive or team who has "pioneered" in the use of social media for marketing, research, or corporate communications purposes. The award has been presented each year beginning in 2010. This presentation highlights the past winners and what they are doing now.
Social Media Guidelines and Safeguards for the Phamaceutical Industry: What Y...Stacy Lukasavitz Steele
This is a POV I wrote in June 2010 advising pharmaceutical companies on what they should do in the social media space until the FDA issues its official guidelines. It will soon be updated.
The thoughts of patients, health advocates, former government officials, bloggers and others who participated in a roundtable discussion that AstraZeneca convened in 2010.
These slides provide an overview of a white paper - “Connecting with Patients, Overcoming Uncertainty” white paper was produced by Envision Solutions, TNS Media Intelligence/Cymfony and law firm Seyfarth Shaw.
Social Listening in the Pharmaceutical IndustryBrandwatch
Changing patient expectations and the increasing influence of social media, together with heightened government regulatory activity and a growing trend of alliances and acquisitions, represent a shifting landscape.
Pharmaceutical companies need to respond dynamically to this evolution by implementing new business models. Next-generation business models must address a number of key factors to position themselves for long-term success, one of which is to listen and ultimately engage in meaningful dialogue with consumers and stakeholders.
Discover:
- Key challenges facing pharmaceutical companies in their forays into social listening
- Benefits of social listening illustrated with reference to a number of case studies drawn from a selection of therapy areas
- Recommendations around how to get started and the role Brandwatch and PharmiWeb Solutions can take to help you achieve business success
Importance of social media in Pharmaceutical industryActiance, Inc.
Guidelines for the pharmaceutical industry are lacking, Novartis had used Facebook and two popular social networking sites, to influence consumers in spreading the word about Tasigna, a cancer drug. The FDA concluded that Novartis’ act failed to meet regulatory and compliance standards. Specifically, the FDA called out Novartis’ marketing as incomplete and misleading since it failed to communicate any risk information associated with the use of Tasigna.
Safety and Social Media Dia webinar 12 sep2013 Michael Ibara
This is a webinar version of a talk I originally gave at a DIA event in Wash DC. I've used different examples from my original talk but the theme is the same.
Navigating FDA’s Social Media Guidelines for Medical Devices.pdfdnyaneshwarivedpatha1
Ensuring Regulatory Compliance and Monitoring in Medical Device Marketing
Compliance and Monitoring
FDA’s Stance on Continued Monitoring of Third-Party Websites and Social Media Platforms
The FDA emphasizes the importance of continued monitoring of third-party websites and social media platforms by medical device companies. This monitoring helps ensure that information related to their products remains accurate, up-to-date, and compliant with regulatory guidelines. Companies are responsible for actively monitoring user-generated content and addressing any misleading or inaccurate information promptly.
Non-Objection to Voluntary Corrections Meeting FDA’s Recommendations
The FDA encourages voluntary corrections by medical device companies to address misinformation or inaccuracies in their marketing materials. When companies take proactive steps to correct such information in line with FDA’s recommendations, the agency generally does not object to these corrective actions. This reflects a collaborative approach between regulatory authorities and industry stakeholders to uphold transparency and accuracy in marketing communications.
Reminder for Companies to Comply with Applicable Regulatory Requirements in Corrective Actions
Medical device companies must ensure that their corrective actions comply with all applicable regulatory requirements set forth by the FDA. This includes providing truthful and non-misleading information, adhering to labeling guidelines, and disclosing affiliations or relationships related to corrective information. Compliance with these requirements is essential to maintain ethical standards and regulatory compliance in marketing practices.
Recommendation for Companies to Maintain Records for Potential FDA Inquiries
As part of regulatory compliance, companies are advised to maintain detailed records of their marketing activities, corrective actions, and communications related to their medical devices. These records serve as evidence of compliance with FDA guidelines and can be valuable in addressing potential inquiries or audits by the FDA. Proper record-keeping demonstrates transparency, accountability, and a commitment to regulatory compliance within the medical device industry.
By adhering to these compliance and monitoring practices, medical device companies can uphold regulatory standards, address misinformation effectively, and maintain trust and credibility among consumers and regulatory authorities alike.
Navigating FDA Guidelines: Best Practices for Medical Device Advertising
Conclusion and Recommendations
Recap of Key Points from FDA’s Proposed Guidelines and Relevant Regulations
Throughout this discussion, we’ve explored the FDA’s proposed guidelines and regulations concerning medical device advertising on social media platforms. Key points include the importance of accurate and balanced communication of benefits and risks, addressing misinformation, and complying with FDA requirements for promotional
Point of view of the recently released draft guidance for industry for pharma and social media by Navicor - an Oncology focused marketing and communications company.
Tweeting Inside the Lines
5 Social Marketing Solutions for Regulated Industries
By Hugh Kennedy, Partner, EVP Planning, Healthcare Practice Lead
The natural conservatism of marketing in regulated industries – healthcare, pharmaceuticals, and financial services – can suck the life out of social media and dull its original intent—to promote direct interaction. But it doesn’t have to be that way. Social media in regulated industries can solve three unique problems. And some brands have caught on. They see that an early mover advantage is still out there for regulated industries, and they are creating thought-provoking content that elevates their brands but doesn’t land them on the wrong side of regulations.
Find out how to join the social media party in a regulated industry from PJA Advertising + Marketing, named a 2013 top midsize agency by B2B Magazine.
…and be sure to follow us on Facebook and Twitter.
Overcoming Pharma’s Social Media Challenges Pharma Guy
I this presentation, I present pharma social media “milestones” or “firsts” that have paved the way for others to follow and identify the “Pioneers” who have helped the industry navigate through “uncharted” territory lacking regulatory guidance.
I also review some “mistakes” made by both leaders and followers. Only those who learn from the mistakes of their competitors will move forward. Those who learn from their OWN mistakes will move forward fastest!
Finally, I offer some ideas for “best practices” and “guiding principles” that may help pharma avoid regulatory actions.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Deal with (LACK) of Regulations, Develop Best Practices
1. A Social Media Strategy John Mack/Pharmaguy Publisher, Pharma marketing News & Pharma Marketing Blog @pharmaguy on Twitter [email_address] Presented at 6th Annual Pharma Marketing & Branding Excellence 25 January 2011 Milano, Italy Deal with (LACK) of Regulations, Develop Best Practices Osso Whaaaat? Mack's Osso Bucco recipe!
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13. This is what happens when you don’t implement a policy for handling user-generated content. S-A’s VOICES: A Reason to Fear Comments
14. sanofi-aventis U.S. Diabetes S-A recently launched a “Diabetes Co-Star” FB page featuring movie actor and diabetic Paul Sorvino. While comments are allowed, so far only comments from S-A have been published. “ Since we operate in a heavily regulated industry, we… must preview all messages.” “ While some messages may not be posted, we are listening and encourage you to continue sharing.” The page has only 522 people who “Like” it, whereas there are dozens of other diabetes FB pages like by thousands of people!
15. Publishes all comments before reviewing, but reserves right to delete comments if offensive or mention ANY product. Psoriasis 360: Comments Allowed! While many pharma companies attempt to shy away from allowing comments on their Facebook & Youtube pages or participating in online patient communities due to AE reporting challenges, a few are undeterred and seem to have figured it out . EU-based companies like Janssen UK and UCB lead the way.
16. “ moderation is about engagement, leading and responding to the community not censorship Negative comments r V valuable” “ If you want to receive the benefits of SM engagement it has to be real, community moderate themselves in the end” “ if a brand, company, person is that worried about comments in SM there is probably a deeper issue under the surface” Thoughts on Social Media Comment Moderation Alex Butler, Digital Strategy and Social Media Manager at Janssen & recipient of first ever Pharmaguy Social Media Pioneer Award, says: Comments made by @Alex__Butler during #hcsmeu chat on 21 Jan 2011. Pharmaguy Social Media Pioneer Lapel Pin
17. Janssen-Cilag on Youtube: Allowing Comments & Likes “ Comments are reviewed before posting - in line with the commenting policy on the site. The vast majority of comments have been posted, Kind regards, Gary” -- Gary Monk , Product Manager. "Here's a hint for pharma. Nothing will go viral if you don't allow 'Likes' or comments. Guaranteed.” -- Jon Richman
18.
19. Roche Social Media Principles “ A significant, albeit, small step in the direction of corporate transparency, normally so difficult to achieve within the pharma industry but so essential if it is to regain the trust that will be crucial for its long-term survival…[yet] so few pharmas have publicly revealed their social media policies. Why is the industry so reticent?” -- Len Starnes, Bayer
20. Pfizer Canada’s SM “Guard Rails” Chart Base on a U.S. Air Force Chart. Guides Pfizer Canada in responding to remarks on social media networks which are either the property of, sponsored by or have a relation of some kind to Pfizer Canada.
21.
22.
23. Contact Me John Mack/Pharmaguy Publisher, Pharma marketing News & Pharma Marketing Blog @pharmaguy on Twitter [email_address]